Micro Exam 4

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/255

encourage image

There's no tags or description

Looks like no tags are added yet.

256 Terms

1
New cards

Viruses

  • Obligate intracelluar microbes

  • smallest infectious agents known

  • incapable of growth or replication outside of a living cell

  • upon entry of virus into a host cell, the cell becomes a “Virus factory” for production of virions


2
New cards

Virsu classifications

  • Classified as DNA or RNA

    • Viral genomes are either DNA or RNA (not both)

      • single strand or double strand DNA or RNA

      • linear or circular


3
New cards

Viral structure

  • Genome

  • Capsid

  • Envelope

  • Nucleocapside

  • Capsomeres


4
New cards

Viral Genome

  • Inner nucleic acid core

    • DNA (ss or ds) or RNA


5
New cards

Viral capsid

  • Structural protein that surrounds and protects the nucleic acid

  • made of capsomeres


6
New cards

Envelope- virus

  • found on larger viruses

  • lipid rich- surrounds virion

  • Responsible for virus entry into host cell

  • may contain glycoprotein spikes, hemagglutinin, neuraminidase, and other structures that stabilize viral attachment to host cell


7
New cards

Nucleocapsid

  • Nucleic acid genome surrounded by a protein coat (capsid_

  • nucleic acid+ capsid


8
New cards

Capsomeres

  • repeating structural units of a capsid

    • capsomeres form capsids and characterisitic virus structure


9
New cards

Step of virus replication

aka infection of host

  1. Attach/ absorption

  2. Get inside host cell/ penetration

  3. Expose nucleic acid/ uncating

  4. makie viral components

  5. assmeble virion

  6. release or integrate


10
New cards

Attach - virus

  • First step up virus replication

  • recognition of suitable host cell

  • specific binding fo virus to host cell

  • Viral tropism


11
New cards

Viral tropism

  • certain predalection virus ahs for a cell

    • ex. hepatitis viruses have a liver tropism


12
New cards

Penetration- virus

  • Second step of virus replication

  • mechanism of virus entry into host cell involving

    • internalization of virus into host cell

    • fusion of neighboring host cells to form multinucleated cells


13
New cards

Syncytis

  • multinucleated cells


14
New cards

Expose nucleic acid

  • Aka uncoating

  • 3rd step of viral replication

    • removal of outer viral capsid


15
New cards

Make viral component

  • 4th step of viral replication

  • macromolecular biosynthesis

    • production of viral nucleic acids, proteins


16
New cards

Assemble the virion

  • Viral components assemble into virus particle

    • nucleic acids, proteins, capsids

  • Viral assembly

    • fifth step of viral repliation


17
New cards

Release/ integrate- virus

  • Release from or integrate into host cell

  • host cells lysis or budding from cytoplasm with minimal damage to host or integrate into the genome

  • 6th step of viral replication


18
New cards

Lysis

  • release of viral particles from lysed host cells

    • vegetative virus state


19
New cards

Lysogeny

  • integration of viral nucleic acid into host genome

  • provirus state/ prophage


20
New cards

Types of Virus Pathogensis

  1. Acute viral infection

  2. LAtent Viral infection

    1. Chronic viral infection


21
New cards

Acute viral infection

  • has evident signs and symptoms


22
New cards

Latent viral infection

  • has no visible signs or symptoms, but virus is present in host cells in lysogenic state

    • inserted into host genome and is inactive until later manifestation


23
New cards

Chronic viral infection

  • persistent

  • low levels detected

  • degree of signs and symptoms vary

  • transmission via fecal oral route or sexually


24
New cards

Measles disease prgrasssion

  1. viral entry into host followed by viremia

  2. inoculation of secondary target tissue distant from primary site

    1. tissue tropism

  3. Second viremia may occur in tissue- specific manner

  4. Symptoms appear

  5. disease resolution occurs and prevents continued viral replication specific antibody response, cell mediated immunity

  6. Tissue damage can result by

    1. lysis of virus-infected host cells

    2. immunopathologic mechanisms directed against virus that also injures host cells

    3. oncogenic potential of some viruses: stimulate uncontrolled growth of host cells


25
New cards

Host response to viral infection

  • innate

    • production of anti viral proteins

  • Adaptive

    • production of antibodies

    • activation of cell mediated immunity


26
New cards

Production of anti-viral proteins

  • Interferons

  • complement cascade activation

    • damage outermost layer of enveloped viruses

    • coats receptors of nonenveloped viruses

  • innate immune response


27
New cards

Interferons

  • activate natural killer cells

  • Innate immune resposne

  • anti viral protein


28
New cards

Production of antibodies- viral

  • Humoral immunity

  • IgA- mucosal

  • IgM- early antibody

  • IgG- later and continued antibody response: antigen memory


29
New cards

Activation of cell mediated immunity

  • T- lymphocytes

    • cytotoxic CD8+, helper cells (CD4+), memory


30
New cards

Methods of viral detection- less common

  • Use of embryonic eggs

    • influenza virus is isolated in embryonic eggs

  • Use of animal inoculation

    • some coxsackie viruses need mice for isolation


31
New cards

Direct detection of virus- commonly used

  • immunodiagnostics/ viral serologies

  • Plaque assays

  • Molecular methods

    • PCR, RT- PCR


32
New cards

Immunodiagnositcs/ viral serologies

  • Paired Sera: Acute, convalescent

  • direct and indirect immunofluroscent

  • enzyme immunoassays

    • EIA or ELISA

  • Latex agglutination

  • immunoperozide stain methods

  • radioimmunoassays

direct detection of virus

33
New cards

Plaque assays

  • Require cell culture: virus- specific cell lines are needed

  • living cells are maintained in vitro for virus isolation

  • direct detection- commonly used


34
New cards

Quantitative Assays

  • Plaque assays

  • lytic viruses only

  • each plaque represents one Plaque forming Unit (PFU)


35
New cards

Plaque assays steps

  1. serial dilution of virion-containing solution

  2. create tissues culture plates

  3. spread diluted virus

  4. overlay with agar- prevents diffusion

  5. count number of plaque


36
New cards

Specimen selection of viral diseases

  • disease syndrome

    • symptoms, signs

  • viral etiologies suspected

  • Time of the year

    • ex. winter is flu season

  • Most viruses enter the host through upper respiratory tract and infect tissues that produce symptoms distant from primary inoculation step

    • ex. aspetic meningitis caused by an enterovirus may be detected in throat, rectal swab or CSF


37
New cards

Most detected viruses in hospitalized US patients

  • Herpes, Influenzae, Hepatits, HIV

  • ID for culture, PCR, assay for antigen detection


38
New cards

Virus prevention

  • immunization available for some viruses

  • thorough and regular hand washing

  • avoid contact with people displaying evident signs and symptoms

    • Fever, cough, diarrhea, respiratory infections


39
New cards

Virus treatment

  1. vaccinations

  2. antivral agents

  3. immune prophylaxis- passive immunity


40
New cards

Antiviral immunity

  • Approximately 40 antiviral drugs are liscensed for clinical use against

    • HIV

    • herpes

    • Varicella- zoster

    • cytomegloirus

    • hepatitis B and C

    • respiratory syncytial virus

    • influenza virus


41
New cards

Immune prophylaxis

  • admin of exogensouly made antibodues to prevent infection in exposed individuals

  • passive immunity against virus

  • ex. admin of antibody rich


42
New cards

Viral Hepatitis

  • Different viruses grouped together, not because of structural or genetic similarities because they share the same tissue tropism

    • The liver

  • Many classifications

  • major significance

  • not limited by geographical, social, or socioeconomic groupings

  • some people have no symtpojms


43
New cards

Earlier hepatitis classifications

  • infectious- transmitted via the fecal oral route

  • Serum- transmitted via transfusion of infected blood or blood products


44
New cards

Current classifications of Hepatitis

  • A

  • B

  • C

  • D

  • E

  • all are extremly different


45
New cards

Common symptoms of viral hepatits

  • Fatigue

  • headache

  • anorexia

  • nausea

  • vomiting

  • abdominal pain

    • right upper quadrant or diffuse

  • Jaundice- most charactersitic

  • Dark urine- most characterisitc

  • disease scenarios are similar because of the tissue tropism


46
New cards

Important to know about viral hepatitis

  • Potential risks for acquiring each type

  • risk behaviors of the patients

  • appropriate diagnostic testing

  • appropriate preventatives/ therapeutics


47
New cards

Viral Hepatitis Panels

  • set of blood tests that identify markers of hepatitis infection


48
New cards

Viral Hepatitis panels uses

  • used to diagnose viral hepatitis

  • used to monitor disease or vaccination status


49
New cards

Diagnose viral hepatits panel use

  • blood and blood products- hepatits negative products must be avilable

  • individuals at risk

    • healthcare works, IV drug users, dialysis patients

  • Pregnant women- minimize transmission to newborn

  • determien hepatitis status

    • ex seroconversion of a patieint from positive to engative hepatitis results

  • Diagnose active cases

  • distinguish type of hepatitis


50
New cards

Monitoring disease or vaccination state- viral hepatitis panel

  • ensure immunity after vaccination

  • monitor success of immunoprophylaxis

  • determine HB status: Seroconversion versus carriers


51
New cards

Heptatitis A

  • HAV

  • ssRNA virus

    • fairly simple

  • Most cases occur in children under 15

  • some children are asymptomatic

  • I month of incubation period

  • infection is self limiting

  • associated with low mortality, no persistance, no chronic liver damage

  • picornaviridae


52
New cards

HAV transmission

  • fecal oral route in most cases

  • sexual or household contact with infected person

  • IV drug use

  • international travel

  • poor sanitation, poor personal hygiene


53
New cards

HAV individuals at risk

  • close contact of infected incividual

  • gay sex

  • children in daycare centers

  • travelers

  • military in areas where clean water and proper sewage disposal is not available


54
New cards

HAV therapy

  • none available


55
New cards

HAV prophylaxis

  • immune globulin as pre exposure preventative for travelers

    • >80% effective

  • Vaccination of children over 2 years

  • vaccines provide long term protection

  • safe effective vaccines available in USA

    • HAvrix- GlaxoSmith-Kline

    • Vaqta


56
New cards

HAV prevention

  • good sanitary habits, practices

  • short term protection possible with immune globulin


57
New cards

Indivatory os HAV immunity

  • Presence of total IgG anti-HAV

  • absence of IgM anti- HAV


58
New cards

Hep A panel

  • HAV Ag

    • serum and stool

  • HAV IgM AB

    • Serum

  • HAV IgG Ab

    • Serum


59
New cards

Hep B

  • HBV

  • dsDNA (partially)

  • enveloped virus

  • Primarily a blood borne pathogen, low amioutns can be found in

    • semen, vaginal fluids, Saliva, other body fluids

      • Contain HBsAg

  • Hepadnaviridae family


60
New cards

main routes of infection HBV

  • Percutaneous

    • through the skin: needles, bites, acupuncture, tattoos, body piercing

  • Permucosal

    • through the mucosa: sexual, perinatal, contact such as toothbrush or razor


61
New cards

HBV viral antigens

  • protein structures that elicit antibody response

  • Surface- HBsAg

  • Core- HBcAg

  • e antigen: HBeAg


62
New cards

People at risk for HBV

  • Sexual contact of acute or chronically infected person

  • IV drug users

  • people with multiple sex partners or history of STD

  • Infants born to mothers with HBV

  • Individuals born to mothers with HBV

  • individuals with occupational contact with blood

  • recipients of unscreened blood ro blood derived products

  • hemodialysis patients- due to poor sterilization

  • Household contact with infected people

  • institutionalized populaitions

  • people born in endemic areas


63
New cards

Acute Serological course of HBV

  • 60-90 day incubation

    • dependent on viral dors, transmission, host factors

  • CLinical illness occurs in 30-50% of people

  • Most HBV infected adults recover within 6 months and develop immunity

  • Some will progress to chronic infection- mostly children

  • 15-25% of chronic HBV pts die due to chronic liver disease


64
New cards

HBV determinants of immunity

  • Anti- HBs is the only marker for determining immunity

    • Suggestive indicators are normal enzyme levels adn HBsAG


65
New cards

HBV prevention

  • Worldwide screening of blood and blood products

  • destruction of disposable needles

    • adequate sterilization of reusable instruments

  • Effective use of Universal precautions and barrier techniques

  • HBIG

  • Hepatitis B vaccination

  • Anti-HBs testing is recommended for certain individuals

  • Anti-HBs quantitive determinations


66
New cards

HBIG

  • Hepatitis B immune Globulin

    • provides temporary, passive HBV protection


67
New cards

Hep B vaccination

  • 1st vaccing produced from plasma of people chronically infected with HBV

  • current vaccine is produced by recombinant DNA tech

    • given as IM doses

      • initial, 30 days later, 6 months after initial dose


68
New cards

Anti HBs testing s recommended for

  • health care workers

  • babies born to HBV infected mothers

  • sex partners of people with chronic HBV infections

  • immunocompromised individuals


69
New cards

Anti- HBs quantitiative determinations are recommended to

  • screen individuals to determine need for initial vaccination

    • if protective antibody levels ar epresent, no need to vaccinate

  • Est. anti- HBs level after vaccination

    • determine whether revaccination is needed

    • How long has it been since initail screening

  • Assess recovery from HBV infection


70
New cards

HBV antigen ELISA

  1. Anti-HBsAg on microwell is used to “capture” Ag in patient serum

  2. Patient serum with antigen

  3. ANti-HBsAg with enzyme label attached

  4. performance of enzyme reaction


71
New cards

HBV antigen ELISA Interpration

  • The higher the enzyme activity, the more hepatitis antibody binds to HBsAg in the patient serum


72
New cards

HBV infection markers

  • Positive- HBsAg

  • Resolved: antiHBs, anti- HBc total

  • HBV vaccination: antiHBs

MArkers are not routinely used for diagnostic purposes

all serum


73
New cards

HBV core window

  • HBsAg neg

  • Anti-HBs pos

  • Anti-HBs neg

  • POSITIV


74
New cards

Anti HBs positive and anti AHBc positive

  • person who had hepatatis B and completely resolved infectio n


75
New cards

Anti HBs positive

successfully vaxed against hep B

76
New cards

HBV follow up after testing

  • HBsAg- persistence leads to chronic HBV infection

  • Anti- HBs- seroconversion from HBsAg to anti HBs positivity indicated resolution of disease and establishment of immunity


77
New cards

HBV complication

  • chronic infection leads to

    • liver damage

    • cirrhosis

    • hepatic liver cncer

    • death


78
New cards

Hep C shape

  • ssRNA positive strand

  • <50 nm in diameter

  • blood born

    • no known cases through other bodily fluids



79
New cards

HCV disease incidence

  • not well known because acute infection is usually asymptomatic

  • non specific symptoms may be present

    • anorexia, malaise, fatigue, abdominal plain

  • 20-30% have jaundice

  • Individuals may be HCV positive yet have normal liver enzyme results


80
New cards

Main routes of HCV infection

  • percutaneous

    • needles, hemodialysis, transfusion of unscreened blood or products, bites, tattoos, acupuncture, body piercing

  • Permucosal

    • sexual, perinatal, contact


81
New cards

HCV

  • leading cause of liver cancer

  • leading cause for liver transplantation in the US

  • most pts have chronic disease

  • estimated 4 million americans are infected

  • according to WHO- 4% of the world population is infected

  • Chronic HCV

    • 60-85% of people with HCB

  • Flaviviridae


82
New cards

Diagnostic testing of HCV

  • Detection of antibodies specific for HCV (anti-HCV) and ruling out other viruses

  • antibodies develop within 12 weeks of exposure in 90% of patients

  • presence of anti-HCV does not distinguish

    • Acute, chronic, resolved

  • supplemental tests exists to confirm anti- HCV results

    • recombinant immunoblot assay RIBA

  • Current anti- HCV assays have been effective in USA at reducing number of post transfusion cases

  • PCR for quantitation of HCV viral load


83
New cards

HCV prophylaxis

  • No vaccine exisits

  • no short term protection exisits

    • no immune globulin


84
New cards

HCV therapy

  • Interferon with or without ribavirin

    • combo therapy is recommended

  • HCV protease inhibitors were approved for medical use in USA in 2013

    • When used in combo with other antiviral drugs, there are 80-90% cure rates with a 12- week treatment course

    • these drugs are show promise in treatment of HBV and HIV


85
New cards

HCV prevention

  • recommended by WHO

    • screening of blood and blood products

    • destruction of disposibale needles

    • universal precautions and barrier techniques

    • education about risks of using unsterilized material and high risk drug and sexual behaviors


86
New cards

HCV panel

  • HCV RNA- serum

  • HCV antibody- Seerum


87
New cards

Acute HCV with recovery panel resuls

  • Anti- HCV palteau

  • no HCV RNA

  • no elevated raised ALT

    • liver function


88
New cards

ALT

  • alanine transaminase

  • liver function test


89
New cards

Hep D

  • HDV

  • ssRNA virus

  • <50 nm in diameter

  • depends on synthesis of HBsAg

    • cannot infected on its own

  • Known as delta hepatitis virus

  • unassigned family

  • deltavirus- smallest known to man


90
New cards

At risk for HDV

  • anyone with or at risk for HBV

    • IV drug users

    • hemophiliacs/ hemodialysis patients

    • people with multiple sexual partners


91
New cards

HDV routes of transmission

  • Similar to those for HBV

  • usually parenteral

  • mucosal contact has been reported

  • perinatal infection is rare


92
New cards

Incidence/ prevalence HDV

  • infects 4% of acute HBV cases in US

  • usually corresponds with prevelance of chronic HBV worldwide


93
New cards

HDV acquired as

  • coinfection with HBV

  • superinfection


94
New cards

HDV superinfection

  • HBV carrier becomes infected with HDV

  • 70-80% of chronic HBV carriers with HDV superinfection develop chronic liver disease with cirrhosis compared to 15-30% with chronic HBV alone


95
New cards

HDV prevention

  • no vaccine exists

  • immunization with HBV vaccine prevents coinfection

  • educated people about reducing risks, changing behaviors


96
New cards

HDV therapy

  • For chronic HBV- HDV infection- follow HBV therapy

  • no therapy currently exists for chronic hep d patients


97
New cards

HDV panel

  • HBsAg- serum

  • HDV RNA- serum

  • HDV IgM Ab- serum

  • HDV total AB- serum


98
New cards

Hep E

  • ssRNA- postive sense

  • <50 nm

  • frequently considered water borne enteric agent


99
New cards

HEV transmission

  • Enteric- fecal oral

    • ingestion of contaminated water supplies or food

    • poor personal hygiene

    • person to person contact


100
New cards

HEV at risk

  • residents and travelers to endemic regions